In ovarian tumor (OT) tissues, DHT enhances the binding of NRF2 to Keap1, resulting in potentiated ubiquitination and degradation of NRF2, thereby activating oxidative stress and exhibiting anti-tumor effects [102]. This evidence concerns the gene NFE2L2 and neoplasm.